BIOLASE (NASDAQ: BIOL) and Sirona Dental Systems (NASDAQ:SIRO) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for BIOLASE and Sirona Dental Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIOLASE 0 0 1 0 3.00
Sirona Dental Systems 0 0 0 0 N/A

BIOLASE currently has a consensus target price of $2.50, suggesting a potential upside of 382.63%. Given BIOLASE’s higher probable upside, equities analysts clearly believe BIOLASE is more favorable than Sirona Dental Systems.

Earnings and Valuation

This table compares BIOLASE and Sirona Dental Systems’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BIOLASE $51.81 million 0.76 -$15.37 million ($0.33) -1.57
Sirona Dental Systems N/A N/A N/A $3.39 32.44

Sirona Dental Systems has lower revenue, but higher earnings than BIOLASE. BIOLASE is trading at a lower price-to-earnings ratio than Sirona Dental Systems, indicating that it is currently the more affordable of the two stocks.


This table compares BIOLASE and Sirona Dental Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BIOLASE -36.28% -74.51% -40.81%
Sirona Dental Systems 17.03% 15.23% 11.01%

Volatility & Risk

BIOLASE has a beta of 2.31, meaning that its stock price is 131% more volatile than the S&P 500. Comparatively, Sirona Dental Systems has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

Institutional and Insider Ownership

38.8% of BIOLASE shares are owned by institutional investors. 7.1% of BIOLASE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.


BIOLASE beats Sirona Dental Systems on 6 of the 11 factors compared between the two stocks.


BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

About Sirona Dental Systems

Sirona Dental Systems, Inc. is a manufacturer of dental equipment. The Company is focused on developing, manufacturing and marketing solutions for dentists around the world. It operates through four segments: Dental CAD/CAM Systems, Imaging Systems, Treatment Centers and Instruments. Its Dental CAD/CAM Systems includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic metal or composite blocks. Its Imaging Systems segment consists of a range of systems for diagnostic imaging in the dental practice. Its Treatment Centers consist of a range of products from basic dentist chairs to chair-based units with integrated diagnostic hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. It offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis.

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with's FREE daily email newsletter.